SMAIO SA
PAR:ALSMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
SMAIO SA
Net Income (Common)
SMAIO SA
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
SMAIO SA
PAR:ALSMA
|
Net Income (Common)
-€2.3m
|
CAGR 3-Years
9%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
Edap Tms SA
NASDAQ:EDAP
|
Net Income (Common)
-€29.2m
|
CAGR 3-Years
-115%
|
CAGR 5-Years
-77%
|
CAGR 10-Years
-33%
|
|
|
Biomerieux SA
PAR:BIM
|
Net Income (Common)
€397.5m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
14%
|
|
|
Diagnostic Medical Systems SA
PAR:ALDMS
|
Net Income (Common)
-€2.9m
|
CAGR 3-Years
9%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Amplitude Surgical SA
PAR:AMPLI
|
Net Income (Common)
€1.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
Mauna Kea Technologies SA
PAR:ALMKT
|
Net Income (Common)
-€10.4m
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
SMAIO SA
Glance View
S.M.A.I.O SA engages in the design, manufacture, and distribution of medical devices for the treatment of spinal pathologies. The company is headquartered in Saint-Priest, Auvergne-Rhone-Alpes and currently employs 30 full-time employees. The company went IPO on 2022-04-06. The firm provides control on a surgical procedure to spine physician through a wide range of solutions like surgical plan/ i-plan, surgical procedure i-perform, outcome data/ i-check, and education/ i-learn. The company operates with the clinical data and imaging for specialists in spine surgery for transformation of the vertebral fusion. The company also offers spine surgeons a complete solution, consisting of software, implantable devices, associated services, and treat spinal pathologies requiring surgery. The company includes Kheiron Spinal Fixation System, a device that incorporates many implants, intended for the immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar and/or sacral spine. The company also develops the Keops and Balance Analyzer 3D surgical planning and patient database management software,
See Also
What is SMAIO SA's Net Income (Common)?
Net Income (Common)
-2.3m
EUR
Based on the financial report for Dec 31, 2024, SMAIO SA's Net Income (Common) amounts to -2.3m EUR.
What is SMAIO SA's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-7%
Over the last year, the Net Income (Common) growth was -426%. The average annual Net Income (Common) growth rates for SMAIO SA have been 9% over the past three years , -7% over the past five years .
